tiprankstipranks
Trending News
More News >
Immuneering (IMRX)
NASDAQ:IMRX
US Market

Immuneering (IMRX) Cash flow

Compare
341 Followers

Immuneering Cash Flow

IMRX's free cash flow for Q4 2024 was $-14.52M. For the 2024 fiscal year, IMRX's free cash flow was decreased by $-5.77M and operating cash flow was $-14.51M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -55.00M$ -48.97M$ -44.10M$ -30.85M$ -14.62M
Investing Cash Flow
$ 26.43M$ 7.30M$ 41.83M$ -75.62M$ -53.41K
Financing Cash Flow
$ 5.30M$ 28.44M$ 19.00K$ 144.26M$ 37.98M
End Cash Position
$ 36.14M$ 59.41M$ 72.64M$ 74.89M$ 37.09M
Free Cash Flow
$ -55.08M$ -49.31M$ -44.84M$ -30.91M$ -14.67M
Currency in USD

Immuneering Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis